These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 33651137)

  • 1. Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes.
    Ghorbani Y; Schwenger KJP; Allard JP
    Eur J Nutr; 2021 Aug; 60(5):2361-2379. PubMed ID: 33651137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics, prebiotics, synbiotics and insulin sensitivity.
    Kim YA; Keogh JB; Clifton PM
    Nutr Res Rev; 2018 Jun; 31(1):35-51. PubMed ID: 29037268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Microbiome Therapies on Waist Circumference, a Measure of Central Obesity, in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Vazquez-Marroquin G; Ochoa-Précoma R; Porchia LM; Pérez-Fuentes R; Nicolás-Toledo L; Rodríguez-Antolín J; Gonzalez-Mejia ME
    J Acad Nutr Diet; 2023 Jun; 123(6):933-952.e1. PubMed ID: 36634870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Synbiotics (Prebiotics and Probiotics) as Dietary Supplements in Type 2 Diabetes Mellitus Induced Health Complications.
    Baghel K; Khan A; Kango N
    J Diet Suppl; 2024; 21(5):677-708. PubMed ID: 38622882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
    Barengolts E
    Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review.
    Vakilpour A; Amini-Salehi E; Soltani Moghadam A; Keivanlou MH; Letafatkar N; Habibi A; Hashemi M; Eslami N; Zare R; Norouzi N; Delam H; Joukar F; Mansour-Ghanaei F; Hassanipour S; Samethadka Nayak S
    Nutr Diabetes; 2024 May; 14(1):25. PubMed ID: 38729941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: A systematic review, meta-analysis, and meta-regression of clinical trials.
    Paul P; Kaul R; Harfouche M; Arabi M; Al-Najjar Y; Sarkar A; Saliba R; Chaari A
    Pharmacol Res; 2022 Nov; 185():106520. PubMed ID: 36272640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prospect for Type 2 Diabetes Mellitus Combined with Exercise and Synbiotics: A Perspective.
    Dewi L; Rosidi A; Noer ER; Ayuningtyas A
    Curr Diabetes Rev; 2021; 17(8):e012821190875. PubMed ID: 33511948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.
    Bock PM; Telo GH; Ramalho R; Sbaraini M; Leivas G; Martins AF; Schaan BD
    Diabetologia; 2021 Jan; 64(1):26-41. PubMed ID: 33047170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics and Prebiotics as Dietary Supplements for the Adjunctive Treatment of Type 2 Diabetes.
    Wang Y; Wen L; Tang H; Qu J; Rao B
    Pol J Microbiol; 2023 Mar; 72(1):3-9. PubMed ID: 36929892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synbiotic Intervention with an Adlay-Based Prebiotic and Probiotics Improved Diet-Induced Metabolic Disturbance in Mice by Modulation of the Gut Microbiota.
    Chiou WC; Chang BH; Tien HH; Cai YL; Fan YC; Chen WJ; Chu HF; Chen YH; Huang C
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of probiotics, prebiotics or synbiotics on jawbone in obese-insulin resistant rats.
    Eaimworawuthikul S; Tunapong W; Chunchai T; Yasom S; Wanchai K; Suntornsaratoon P; Charoenphandhu N; Thiennimitr P; Chattipakorn N; Chattipakorn SC
    Eur J Nutr; 2019 Oct; 58(7):2801-2810. PubMed ID: 30251017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut-Microbial Metabolites, Probiotics and Their Roles in Type 2 Diabetes.
    Zhai L; Wu J; Lam YY; Kwan HY; Bian ZX; Wong HLX
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats.
    Chunchai T; Thunapong W; Yasom S; Wanchai K; Eaimworawuthikul S; Metzler G; Lungkaphin A; Pongchaidecha A; Sirilun S; Chaiyasut C; Pratchayasakul W; Thiennimitr P; Chattipakorn N; Chattipakorn SC
    J Neuroinflammation; 2018 Jan; 15(1):11. PubMed ID: 29316965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review.
    Baldi S; Mundula T; Nannini G; Amedei A
    World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin-resistant rats.
    Tunapong W; Apaijai N; Yasom S; Tanajak P; Wanchai K; Chunchai T; Kerdphoo S; Eaimworawuthikul S; Thiennimitr P; Pongchaidecha A; Lungkaphin A; Pratchayasakul W; Chattipakorn SC; Chattipakorn N
    Eur J Nutr; 2018 Sep; 57(6):2091-2104. PubMed ID: 28608320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
    da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
    Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
    Wu J; Yang K; Fan H; Wei M; Xiong Q
    Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of probiotics, prebiotics, and synbiotics for type 2 diabetes management: A systematic review and network meta-analysis.
    Jayedi A; Aletaha A; Zeraattalab-Motlagh S; Shahinfar H; Mohammadpour S; Mirrafiei A; Jibril AT; Soltani A; Shab-Bidar S
    Diabetes Metab Syndr; 2024 Jan; 18(1):102923. PubMed ID: 38134725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.